NS · Healthcare

Aspira Pathlab & Diagnostics Ltd (540788)

Healthcare Services

Aspira Pathlab & Diagnostics Ltd (540788) is listed on NS in the Healthcare sector. Industry: Healthcare Services. As of 2026-07-10, reported market cap is $1.30B, P/E ratio is 2,529.00, net margin is -3.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 540788

Market cap

$1.30B

P/E ratio

2,529.00

Net margin

-3.4%

Aspira Pathlab & Diagnostics Ltd (540788) — FAQ

What is Aspira Pathlab & Diagnostics Ltd's market cap?

Aspira Pathlab & Diagnostics Ltd (540788) has a reported market cap of $1.30B (data as of 2026-07-10).

What is 540788's P/E ratio?

The price-to-earnings (P/E) ratio for Aspira Pathlab & Diagnostics Ltd (540788) is 2,529.00 (data as of 2026-07-10).

Does Aspira Pathlab & Diagnostics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Aspira Pathlab & Diagnostics Ltd (540788). Check the MyAverix Finance app for the latest dividend data.

What sector is Aspira Pathlab & Diagnostics Ltd in?

Aspira Pathlab & Diagnostics Ltd (540788) is classified in the Healthcare sector (Healthcare Services industry).

What exchange is 540788 listed on?

540788 is listed on NS.

What is Aspira Pathlab & Diagnostics Ltd's net margin?

Aspira Pathlab & Diagnostics Ltd (540788) reports a net margin of -3.4% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)